Skip to main content
Premium Trial:

Request an Annual Quote

P23 Labs Receives FDA Emergency Use Authorization for SARS-CoV-2 Test

NEW YORK – P23 Labs has received Emergency Use Authorization for its coronavirus PCR test from the US Food and Drug Administration.

The TaqPath SARS-CoV-2 test is authorized for use with oropharyngeal, nasopharyngeal, anterior nasal, and mid-turbinate nasal swabs, as well as nasopharyngeal wash, nasal aspirate specimens, and bronchoalveolar lavage samples. In addition, it can use saliva samples collected using OraSure Technologies' Omnigene Oral OM-505 saliva collection device.

The kit, from OraSure subsidiary DNA Genotek, allows patients to self-collect oral fluid samples at home with support from a clinician via telemedicine, in an assisted living setting, at a doctor's office, or at a drive through collection site. Self-collection reduces the chance of virus spread to healthcare workers and lowers demand for personal protective equipment, OraSure said. 

P23 Labs relied on usability studies from DNA Genotek's 510(k) clearance for Omnigene to reduce the time required to submit its EUA application, OraSure said.

"This EUA with DNA Genotek's collection device will enable testing for people that do not have the ability to get to a collection center or are at home because they are sick, quarantined, at increased risk for infection, or simply concerned about exposing themselves by traveling to a collection site," Eddie McIntyre, executive VP for technology and logistics at P23 Labs, said in a statement.

In April, OraSure's Oracollect RNA kit was included as the collection device for nasal samples for Biocerna's EUA. The same month, OraSure was awarded a $710,310 contract from the Department of Health and Human Services' Biomedical Advanced Research and Development Authority to develop a pan-SARS-coronavirus antigen self-test using oral fluid samples.  

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.